Stay updated with breaking news from Aezs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $28.00 price target on shares of Aeterna Zentaris in a research note on Thursday, […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a research note on Thursday, […]
And themselves, which is the main thin... ., 4' thing. what you think will happen from here on _ thing. what you think will happen from here on in? _ thing. what you think will happen from here on in? do _ thing. what you think will happen from here on in? do you - thing. what you think will happen from here on in? do you think- thing. what you think will happen from here on in? do you think it i from here on in? do you think it will keep building? if you look at all the people down here now, it is incredible. more than 1000 people came down here and we were saying there are men here as well. ...
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a research note […]
HC Wainwright restated their buy rating on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Thursday morning, Benzinga reports. HC Wainwright currently has a $28.00 target price on the biopharmaceutical company’s stock. Separately, StockNews.com began coverage on shares of Aeterna Zentaris in a report on Thursday. They set a […]